CERT Stock Cash Flow Statements

Certara Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Certara Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31

cash flows from operating activities:
net income	-1,968,000	4,743,000	6,577,000	-1,371,000	-12,574,000	-4,683,000	-12,456,000	-48,965,000	4,706,000	1,358,000	9,174,000	3,936,000	-589,000	2,210,000	-9,699,000	-1,762,000	-2,857,000	1,052,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization
amortization of debt issuance costs	145,000	144,000	144,000	142,000	369,000	380,000	381,000	381,000	382,000	383,000	384,000	385,000	385,000	386,000	387,000	397,000	369,000	378,000
benefit from credit losses	79,000	322,000					632,000	224,000
equity-based compensation expense	8,245,000	7,070,000	7,731,000	8,187,000	9,783,000	9,073,000	7,502,000	8,645,000	3,610,000	8,543,000	6,527,000	6,804,000	9,501,000	7,513,000	8,637,000	8,165,000	7,530,000	5,151,000
change in fair value of contingent considerations	-5,722,000	-179,000	-3,000	2,431,000	2,783,000	2,878,000	12,802,000	8,757,000
deferred income taxes	-12,471,000	10,502,000	-69,000	789,000	-8,586,000	-4,829,000	2,009,000	-8,295,000	-8,713,000	-1,524,000	-8,302,000	2,398,000	-4,892,000	-715,000	-2,980,000	3,767,000	-1,983,000	12,000
changes in assets and liabilities:
accounts receivable	-3,263,000	8,736,000	-5,252,000	-4,367,000	-10,241,000	3,635,000	-6,289,000	6,713,000	-919,000	647,000	-7,114,000	-2,189,000	-2,462,000	-3,244,000	-3,918,000	-6,768,000	622,000	-2,000
prepaid expenses and other assets	4,301,000	1,807,000		-2,168,000	273,000	-578,000		-409,000				-377,000	3,933,000	653,000	6,089,000
accounts payable, accrued expenses, and other liabilities	13,891,000	-27,783,000		-1,469,000	6,520,000	-14,825,000
deferred revenues	-4,213,000	-5,448,000		-2,784,000	3,933,000	-3,271,000
other operating activities	0	-1,176,000	389,000
net cash from operating activities	17,842,000	17,352,000	49,369,000	16,987,000	9,814,000	4,296,000	23,326,000	31,414,000	18,058,000	9,957,000	35,485,000	23,996,000	23,259,000	9,803,000	20,831,000	20,001,000	14,622,000	4,934,000
cash flows from investing activities:
capital expenditures	64,000	-600,000	-415,000	-164,000	-427,000	-619,000	-878,000	-311,000	-271,000	-317,000	-181,000	-390,000	-353,000	-506,000	-148,000	-484,000	-289,000	-222,000
free cash flows	17,906,000	16,752,000	48,954,000	16,823,000	9,387,000	3,677,000	22,448,000	31,103,000	17,787,000	9,640,000	35,304,000	23,606,000	22,906,000	9,297,000	20,683,000	19,517,000	14,333,000	4,712,000
capitalized software development costs	-7,025,000	-5,174,000	-5,421,000	-5,344,000	-5,692,000	-2,959,000
net cash from investing activities	-6,961,000	-5,774,000	-97,163,000	-5,508,000	-6,119,000	-3,578,000	-61,047,000	-4,041,000	-11,731,000	-2,731,000	-12,599,000	-3,324,000	-3,238,000	-8,676,000	-249,323,000	-2,600,000	-14,541,000	-3,458,000
cash flows from financing activities:
proceeds from borrowings on term loan debt			0	0
payment of debt issuance costs			0	0											0	-11,000
payments on long-term debt	-750,000	-750,000
common stock repurchase program
payments for business acquisition related contingent consideration	0	-13,230,000	0	-4,730,000	-1,777,000	-8,649,000
payment of taxes on shares withheld for employee taxes	-4,944,000	-16,000		-125,000	-7,067,000	-943,000		-170,000				-515,000	-2,264,000	-48,000
net cash from financing activities	-30,694,000	-13,996,000	-1,303,000	-5,605,000	-3,755,000	-10,347,000	-1,252,000						-3,531,000	-1,520,000	-3,644,000	132,200,000	-4,310,000	-855,000
effect of foreign exchange rate on cash and cash equivalents	2,993,000	2,321,000
net decrease in cash and cash equivalents
cash and cash equivalents, and restricted cash, at beginning of period				0	0	234,951,000		0	0	239,688,000		0	0	186,624,000		0
cash and cash equivalents, and restricted cash, at end of period				8,424,000	-177,000	224,776,000		24,102,000	972,000	247,238,000		15,533,000	13,190,000	185,060,000		148,363,000
supplemental disclosures of cash flow information
cash paid for interest	4,652,000	4,648,000	11,566,000	-1,515,000	7,291,000	5,395,000	5,421,000	5,413,000	3,059,000	5,196,000	4,958,000	4,842,000	3,921,000	3,547,000	3,498,000	3,557,000	3,562,000	3,552,000
cash paid for taxes	5,351,000	688,000	3,028,000	3,131,000	4,859,000	3,640,000	6,955,000	3,331,000	8,517,000	517,000	2,357,000	2,226,000	2,789,000	2,769,000	1,851,000	2,324,000	2,776,000	1,644,000
supplemental schedule of noncash investing and financing activities
stock issuance or establish liabilities related to business acquisition contingent consideration	0	5,670,000		0
adjustments to reconcile net income (loss ) to net cash from operating activities:
depreciation and amortization of property and equipment		873,000	672,000	439,000	451,000	432,000	413,000	367,000	361,000	411,000	410,000	417,000	422,000	482,000	448,000	533,000	552,000	602,000
amortization of intangible assets		17,741,000	17,544,000	16,353,000	16,146,000	15,996,000	14,420,000	13,813,000	13,173,000	13,113,000	12,732,000	12,846,000	12,711,000	12,450,000	12,545,000	10,208,000	10,125,000	10,102,000
goodwill impairment							0
net decrease in cash and cash equivalents, and restricted cash		-97,000
cash and cash equivalents at beginning of period		179,183,000
cash and cash equivalents at end of period		179,086,000
changes in assets and liabilities
prepaid and other assets										559,000
accounts payable and accrued expenses, and other liabilities
deferred revenue							7,006,000	-4,895,000	-1,049,000	-1,034,000	11,257,000	-4,913,000	630,000	2,556,000			-550,000	-507,000
investment in intangible assets							0	0	0	-54,000
business acquisitions, net of cash acquired							-56,678,000	0			-9,425,000	0	100,000	-5,983,000	-246,906,000	0	-12,070,000	-2,044,000
payments on long-term debt and finance lease obligations			-750,000	-750,000	0	-755,000	-755,000	-755,000	-755,000	-780,000	-830,000	-829,000	-828,000	-826,000
payments on financing component of interest rate swap											-3,000	0	-439,000	-646,000	-879,000
payment of taxes on shares and units withheld for employee taxes										-70,000
effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash																		-191,000
net increase in cash, cash equivalents, and restricted cash																		430,000
cash, cash equivalents, and restricted cash, at beginning of year
cash, cash equivalents, and restricted cash, at end of year
contingent liabilities established in connection with business acquisition							10,518,000	0
stock issuance related to business acquisition contingent consideration
(recovery of) benefit from credit losses				-414,000	748,000	59,000				-168,000			183,000	34,000
effect of foreign exchange rate on cash and cash equivalents, and restricted cash				2,550,000
net increase in cash and cash equivalents, and restricted cash				8,424,000	-177,000	-10,175,000		24,102,000	972,000	7,550,000		15,533,000	13,190,000	-1,564,000		148,363,000
loss on extinguishing debt
loss on retirement of assets							36,000	0	25,000	4,000	113,000	49,000	2,000	5,000	47,000	22,000
lease abandonment expense					0	29,000	0
effect of foreign exchange rate changes on cash and cash equivalents, and restricted cash						-546,000		-2,346,000	1,065,000	1,174,000		-3,795,000	-3,300,000	-1,171,000		-1,238,000
issuance of common stock for business acquisition related contingent consideration						3,707,000
unrealized loss on derivative
proceeds from issuance of common stock, net of underwriters' discounts and commissions
proceeds from borrowings on long-term debt															0	0
payment of deferred offering costs
operating right-of-use assets recognized upon adoption of asc 842
operating lease liability recognized upon adoption of asc 842
common shares issued in connections with the pinnacle acquisition
accounts payable and accrued expenses								6,785,000	5,853,000	-14,196,000							-2,668,000	-11,180,000
other liabilities
capitalized development costs								-3,730,000	-3,910,000	-2,360,000		-2,934,000	-2,985,000	-2,187,000	-2,269,000	-2,116,000	-2,182,000	-1,192,000
supplemental schedule of non-cash investing and financing activities
change in other liabilities										600,000
net cash used by financing activities									-6,420,000	-850,000
change in fair value of contingent consideration										1,261,000

capital contributions
unit repurchase
proceeds from line of credit
payments on line of credit
property and equipment controlled through capital lease obligations
deferred offering costs, accrued but not paid
unrealized loss on interest rate swap																-640,000
accounts payable and other liabilities												4,530,000	3,896,000	-11,830,000
other current liabilities												441,000	-737,000	-792,000
changes in operating lease assets and liabilities												-582,000	276,000	95,000
net proceeds from public offering of common stock
net cash (used) provided by financing activities
liabilities assumed in connection with business acquisition																0	991,000	921,000
changes in assets and liabilities, net of acquisitions:
cash, cash equivalents, and restricted cash, at beginning of period																		273,291,000
cash, cash equivalents, and restricted cash, at end of period																		273,721,000
benefit from doubtful accounts
payments on long-term debt and capital lease obligations																-824,000	-1,468,000	-855,000
proceeds from borrowings from affiliate
capital lease
recovery of doubtful accounts																	-60,000	-1,000
prepaid expenses and other current assets																	870,000	-673,000
property and equipment controlled through new capital leases
(recovery of) benefit from doubtful accounts
equity compensation expense
proceeds from issuance of common stock upon initial public offering, net of underwriters’ discounts and commissions
payments of deferred offering costs
payment of contingent consideration obligations

We provide you with 20 years of cash flow statements for Certara stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Certara stock. Explore the full financial landscape of Certara stock with our expertly curated income statements.

The information provided in this report about Certara stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.